REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/06/2026
Voltar para busca
Dado oficial do USPTO
GENEOSCOPY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
02/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 44
Data de depósito
18/10/2016
Data de registro
01/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/06/2021
Última transação
02/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/10/2019
Primeiro uso no comércio
01/10/2019
Código do desenho
4
Tipo de titular
03
Localização do titular
ST. LOUIS, MO, US
Examinador
GOODWIN, KATRINA JOYE
Localização atual
Historical data usage
Titulares e representantes
Titulares
GENEOSCOPY, INC.
Geneoscopy, LLC
Representantes
MATTHEW J. SMITH POLSINELLI PC
Classificação técnica
Classes Nice
Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic biomarkers for medical purposes for detecting cancer; Diagnostic preparations for medical purposes; biological preparations for the treatment of cancer
Classe 44
Medical screening services in the field of cancer; Medical analysis for the diagnosis and treatment of cancer; medical diagnostic testingmonitoring and reporting services; medical testing for diagnostic or treatment purposes in the field of cancer; Health care servicesfor treating cancer; medical diagnosis and treatment of cancer; medical diagnosis of cancer; medical evaluation of cancer; medical services in the field of cancer; diagnostic services including testing for cancer markersincluding in a patient's excrement such as stool samples; providing a website featuring information in the field of the diagnosis and treatment of cancer; providing cancer screening services; providing information in the field of cancer preventionscreeningdiagnosis and treatment; providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; providing information relating to diagnostics
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
18/03/2025
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
25/02/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
21/02/2025
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
18/02/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/02/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/09/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
28/08/2024
EXPT
EXPARTE APPEAL TERMINATED
01/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30/04/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
29/04/2021
EXPI
EX PARTE APPEAL-INSTITUTED
07/04/2021
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
07/04/2021
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
07/04/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/01/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/10/2020
GNFR
FINAL REFUSAL E-MAILED
08/10/2020
CNFR
SU - FINAL REFUSAL - WRITTEN
08/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/09/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/05/2020
GNRT
NON-FINAL ACTION E-MAILED
26/05/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
26/05/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/05/2020
IUAF
USE AMENDMENT FILED
08/05/2020
EISU
TEAS STATEMENT OF USE RECEIVED
08/05/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
31/10/2019
EX5G
SOU EXTENSION 5 GRANTED
30/10/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
28/10/2019
EXT5
SOU EXTENSION 5 FILED
24/10/2019
EEXT
SOU TEAS EXTENSION RECEIVED
24/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/04/2019
EX4G
SOU EXTENSION 4 GRANTED
15/04/2019
EXT4
SOU EXTENSION 4 FILED
15/04/2019
EEXT
SOU TEAS EXTENSION RECEIVED
15/04/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/09/2018
EX3G
SOU EXTENSION 3 GRANTED
10/09/2018
EXT3
SOU EXTENSION 3 FILED
10/09/2018
EEXT
SOU TEAS EXTENSION RECEIVED
10/09/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/05/2018
EX2G
SOU EXTENSION 2 GRANTED
09/05/2018
EXT2
SOU EXTENSION 2 FILED
09/05/2018
EEXT
SOU TEAS EXTENSION RECEIVED
09/05/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/05/2017
EX1G
SOU EXTENSION 1 GRANTED
24/05/2017
EXT1
SOU EXTENSION 1 FILED
24/05/2017
EEXT
SOU TEAS EXTENSION RECEIVED
24/05/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/05/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/03/2017
PUBO
PUBLISHED FOR OPPOSITION
14/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
31/01/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
31/01/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
31/01/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
31/01/2017
DOCK
ASSIGNED TO EXAMINER
26/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/10/2016
NWAP
NEW APPLICATION ENTERED
21/10/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENEOSCOPY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.